By
World Health Organization
Published: Aug. 17, 2022, 9:41 p.m.·
Tags:
Global TB response,
Advocacy
WHO Director-General and WHO Civil Society Task Force on TB release a joint statement setting collective priorities in preparation for the 2023 UN High-Level Meeting on TB.
Read More →
By
Treatment Action Group
Published: Aug. 1, 2022, 4 p.m.·
Tags:
Global TB response,
Advocacy
At the International AIDS Conference in Montreal, civil society and activist organizations launched a new campaign inspired by the legacy of the late Dr. Paul Farmer calling for the “staff, stuff, space, systems, and support” necessary for shorter, effective TB treatment regimens to reach all who need them as a human right by the end of 2024.
Read More →
By
Unitaid
Published: Aug. 1, 2022, noon·
Tags:
Prevention,
Access
Partners announce two new agreements to lower the price of rifapentine-based treatments to prevent TB in low- and middle-income countries.
Read More →
By
Treatment Action Group
Published: July 21, 2022, 3:37 p.m.·
Tags:
Advocacy,
Access,
Research and development,
Global TB response,
TB CAB
In 2021, TB CAB celebrated its tenth anniversary of advocating for community engagement in research and improved access to TB prevention, treatment, and diagnostic technologies.
Read More →
By
World Health Organization
Published: July 12, 2022, 8:59 p.m.·
Tags:
Vaccines,
Scientific research,
Research and development
The World Health Organization releases the first-ever report on the pipeline of the vaccines currently in development to prevent infections caused by antimicrobial-resistant bacterial pathogens.
Read More →
By
World Health Organization
Published: July 11, 2022, 9:19 p.m.·
Tags:
TB care,
Guidelines
The World Health Organization releases updated guidelines and a new operational handbook on TB care and support to improve the quality of life and better outcomes for people with TB.
Read More →
By
Stop TB Partnership
Published: July 6, 2022, 3:06 p.m.·
Tags:
Global TB response,
Advocacy
The Global Plan to End TB 2023-2030 outlines the priority actions and estimated financial resources needed to end TB as a global health threat by 2030.
Read More →
By
TB activists
Published: July 1, 2022, 7:38 p.m.·
Tags:
Drug-resistant TB,
Treatment,
Access,
Advocacy
Communities affected by TB everywhere have a right to benefit from scientific progress, including access to short-course, bedaquiline-based treatment regimens for drug-resistant TB.
Read More →
By
Global TB Caucus
Published: June 14, 2022, 3:54 p.m.·
Tags:
Public health,
Advocacy
The Global TB Caucus releases an analysis examining the region’s laws on public health, health systems, labor, TB, and other infectious diseases.
Read More →
By
World Health Organization
Published: May 25, 2022, 5:22 p.m.·
Tags:
Drug-susceptible TB,
Treatment,
Guidelines
The updated WHO consolidated guidelines on treatment of drug-susceptible TB include a new recommendation for the use of a 4-month regimen composed of isoniazid, rifapentine, moxifloxacin and pyrazinamid.
Read More →
Page 1 of 116 · Total posts: 10
1
2
Last→